BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novavax, Inc. 

9920 Belward Campus Drive

Rockville  Maryland  20850  U.S.A.
Phone: 240-268-2000 Fax: n/a


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Delivery





 Company News
U.S. FDA Grants Fast Track Designation To Novavax, Inc. (NVAX)' RSV F-Protein Nanoparticle Vaccine For Protection Of Infants Via Maternal Immunization 11/20/2014 7:24:38 AM
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of Quadrivalent Seasonal Influenza VLP 11/17/2014 2:33:59 PM
Novavax, Inc. (NVAX) To Present At The Jefferies and Co. Global Healthcare Conference 11/13/2014 10:47:30 AM
Novavax, Inc. (NVAX) Initiates Phase 1 Clinical Trial Of RSV F Vaccine In Pediatric Subjects 11/10/2014 7:21:03 AM
Novavax, Inc. (NVAX) And Collaborators Make Multiple Presentations At The 9th International Respiratory Syncytial Virus Symposium In South Africa, November 9 - 13, 2014 11/7/2014 10:26:50 AM
Novavax, Inc. (NVAX) Reports Third Quarter 2014 Financial Results 11/6/2014 8:44:50 AM
FDA Grants Fast Track Designation To Novavax, Inc. (NVAX)' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M™ 10/30/2014 10:07:37 AM
Novavax, Inc. (NVAX) To Host Conference Call To Discuss Third Quarter 2014 Financial Results On November 5, 2014 10/30/2014 8:34:01 AM
Novavax, Inc. (NVAX) Announces Ebola Vaccine Development Program At The 8th Vaccine And ISV Conference In Philadelphia 10/27/2014 10:16:50 AM
Novavax, Inc. (NVAX) Presents RSV F Protein Nanoparticle Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26 10/27/2014 10:10:00 AM
12345678910...